Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines.

Patel A, Dong JC, Trost B, Richardson JS, Tohme S, Babiuk S, Kusalik A, Kung SK, Kobinger GP.

PLoS One. 2012;7(8):e43802. doi: 10.1371/journal.pone.0043802.

2.

Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.

Even-Or O, Samira S, Rochlin E, Balasingam S, Mann AJ, Lambkin-Williams R, Spira J, Goldwaser I, Ellis R, Barenholz Y.

Vaccine. 2010 Sep 7;28(39):6527-41. doi: 10.1016/j.vaccine.2010.04.011.

PMID:
20412874
3.

Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.

Liu G, Song L, Reiserova L, Trivedi U, Li H, Liu X, Noah D, Hou F, Weaver B, Tussey L.

Vaccine. 2012 Nov 6;30(48):6833-8. doi: 10.1016/j.vaccine.2012.09.013.

PMID:
23000130
4.

Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.

Major D, Chichester JA, Pathirana RD, Guilfoyle K, Shoji Y, Guzman CA, Yusibov V, Cox RJ.

Hum Vaccin Immunother. 2015;11(5):1235-43. doi: 10.4161/21645515.2014.988554.

5.

Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes.

Tan L, Lu H, Zhang D, Tian M, Hu B, Wang Z, Jin N.

Virol J. 2010 Dec 7;7:363. doi: 10.1186/1743-422X-7-363.

6.

Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.

Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E.

Vaccine. 2009 Aug 27;27(39):5393-401. doi: 10.1016/j.vaccine.2009.06.081.

PMID:
19596415
7.

Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination.

O E, Lee YT, Ko EJ, Kim KH, Lee YN, Song JM, Kwon YM, Kim MC, Perez DR, Kang SM.

J Virol. 2014 Jul;88(14):7764-75. doi: 10.1128/JVI.00748-14.

8.

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.

Brazzoli M, Magini D, Bonci A, Buccato S, Giovani C, Kratzer R, Zurli V, Mangiavacchi S, Casini D, Brito LM, De Gregorio E, Mason PW, Ulmer JB, Geall AJ, Bertholet S.

J Virol. 2015 Oct 14;90(1):332-44. doi: 10.1128/JVI.01786-15.

9.
10.

Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.

Pillet S, Racine T, Nfon C, Di Lenardo TZ, Babiuk S, Ward BJ, Kobinger GP, Landry N.

Vaccine. 2015 Nov 17;33(46):6282-9. doi: 10.1016/j.vaccine.2015.09.065.

PMID:
26432915
11.

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.

Rosendahl Huber SK, Camps MG, Jacobi RH, Mouthaan J, van Dijken H, van Beek J, Ossendorp F, de Jonge J.

PLoS One. 2015 Jun 5;10(6):e0127969. doi: 10.1371/journal.pone.0127969.

12.

Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.

Patel A, Gray M, Li Y, Kobasa D, Yao X, Kobinger GP.

Vaccine. 2012 Jan 11;30(3):626-36. doi: 10.1016/j.vaccine.2011.11.017.

PMID:
22119588
13.

Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus.

Hung JT, Tsai YC, Lin WD, Jan JT, Lin KH, Huang JR, Cheng JY, Chen MW, Wong CH, Yu AL.

Antiviral Res. 2014 Jul;107:110-8. doi: 10.1016/j.antiviral.2014.04.007.

PMID:
24786174
14.
15.

[Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].

Chen H, Deng Y, Tan W, Wang W, Yin X, Guan J, Wang W, Ruan L.

Sheng Wu Gong Cheng Xue Bao. 2010 Jan;26(1):74-8. Chinese.

PMID:
20353095
16.

CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets.

Martel CJ, Agger EM, Poulsen JJ, Hammer Jensen T, Andresen L, Christensen D, Nielsen LP, Blixenkrone-Møller M, Andersen P, Aasted B.

PLoS One. 2011;6(8):e22891. doi: 10.1371/journal.pone.0022891.

17.
18.

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.

Hessel A, Schwendinger M, Fritz D, Coulibaly S, Holzer GW, Sabarth N, Kistner O, Wodal W, Kerschbaum A, Savidis-Dacho H, Crowe BA, Kreil TR, Barrett PN, Falkner FG.

PLoS One. 2010 Aug 16;5(8):e12217. doi: 10.1371/journal.pone.0012217.

20.

Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.

Rider BJ, Fraga E, Yu Q, Singh B.

Mol Immunol. 1996 May-Jun;33(7-8):625-33.

PMID:
8760274
Items per page

Supplemental Content

Support Center